News Release

GNI Group Ltd. Announces a Licensing Agreement for its IPF therapy drug Etuary with AFT Pharmaceuticals for the ASEAN, Australasian and CIS Markets

• Notice for Large Volume Exercise of the 37th Round of Stock Option
• Notice for Exercise of the 37th Round of Stock Options in November, 2013